In Memoriam: Noel R. Rose, 1927-2020
Noel R. Rose, MD, PhD, a longtime Johns Hopkins Bloomberg School of Public Health faculty member and researcher recognized as a father of autoimmune disease research, died Thursday. Rose, 92, died at
Related Articles
Batch correction methods used in single cell RNA-sequencing analyses are often poorly calibrated
As the number of experiments that employ single-cell RNA-sequencing (scRNA-seq) grows it opens up the possibility of combining results across experiments or processing cells from…
Persistent immune responses in the heart determine the outcome of cardiomyopathy syndrome in Atlantic salmon (Salmo salar)
Cardiomyopathy syndrome (CMS) caused by piscine myocarditis virus (PMCV) is a severe cardiac disease in Atlantic salmon (Salmo salar) and one of the l…
Organ aging signatures in the plasma proteome track health and disease
Nature – Blood plasma protein data was combined with machine learning models for a simple method to determine differences in organ-specific aging; the study provides…
Despite sexual harassment shadow, biologist David Sabatini lands job at top Czech institute
Institute director says, “He has been punished enough,” but Czech scientists are divided
LAG-3 as the third checkpoint inhibitor
Nature Immunology – LAG-3 is a T cell inhibitory receptor with a lot of promise as a target for immunotherapy, but considerable research will be…
Opill: The First Over-the-Counter Daily Oral Contraceptive | Johns Hopkins Bloomberg School of Public Health
The FDA’s approval of Opill, the first OTC oral contraceptive pill, is coming at an opportune time. But will it be affordable and, most importantly,…
Lyme disease isn’t the only tickborne disease to watch. | Johns Hopkins Bloomberg School of Public Health
Tickborne diseases are on the rise across the U.S. A tick expert explains the diseases to watch for and how best to avoid them.
Lyme disease isn’t the only tickborne disease to watch. | Johns Hopkins Bloomberg School of Public Health
Tickborne diseases are on the rise across the U.S. A tick expert explains the diseases to watch for and how best to avoid them.
Opill: The First Over-the-Counter Daily Oral Contraceptive | Johns Hopkins Bloomberg School of Public Health
The FDA’s approval of Opill, the first OTC oral contraceptive pill, is coming at an opportune time. But will it be affordable and, most importantly,…